Cedar Grove, NJ, United States of America

Guiseppe F Weber

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guiseppe F Weber. Retrieved from https://idiyas.com/inventor/guiseppe-f-weber

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Guiseppe F Weber: Innovator in Pharmaceutical Chemistry

Introduction

Guiseppe F Weber is a notable inventor based in Cedar Grove, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on chemical compounds.

Latest Patents

Weber holds a patent for 4-oxo-3,4-dihydro-2H-1-benzopyranyloxy alkanoic acid derivatives. This invention relates to compounds of a specific formula, wherein various substituents can be hydrogen or lower alkyl, halogen, or aralkyl. The compounds are designed to have potential pharmaceutical applications, particularly when R.sup.5 is hydrogen, as they can form salts with pharmaceutically acceptable bases. He has 1 patent to his name.

Career Highlights

Guiseppe F Weber is associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work there has allowed him to focus on developing innovative compounds that can have significant therapeutic benefits.

Collaborations

Weber collaborates with Noal Cohen, contributing to the advancement of their research and development efforts in the pharmaceutical sector.

Conclusion

Guiseppe F Weber's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a significant inventor in the industry. His work continues to influence the development of new therapeutic compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…